Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study. J of Skin. 2020;4(1):S12. Accessed June 9, 2025. https://skin.dermsquared.com/skin/article/view/826